(Q51326117)

English

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

scientific article published on 15 April 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Evanthia Diamanti-Kandarakis

7

object named as

Evanthia Diamanti-Kandarakis

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

author name string

Ioannis I Androulakis

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Eleni Kandaraki

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Charikleia Christakou

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Athansios Karachalios

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Evangelos Marinakis

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Thomas Paterakis

6

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

publication date

15 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

81

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

426-431

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Correlates between hyperinsulinism and hyperandrogenemia?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Indices of low-grade inflammation in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Platelet Dysfunction in Lean Women with Polycystic Ovary Syndrome and Association with Insulin Sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FCEN.12447

21 January 2018

Identifiers

10.1111/CEN.12447

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/24601936

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51326117&oldid=2116938611"